Let's not forget: if Leronlimab had been approved for HIV when it should/would have been had Amarex done the work properly, it would have been a PREVIOUSLY-APPROVED drug that could have been used immediately off-label for COVID.
How many people died because Leronlimab was not already approved and being commercially manufactured?
Less importantly than lives the company could have saved, how much revenue did CYDY lose because it was not approved pre-COVID?